The Pharmaceutical Journal
Vol 269 No 7227 p801
7 December 2002

This article
Reprint
Photocopy

News summary

Chairman for new regulatory agency

Professor Alasdair Breckenridge has been appointed chairman-designate of the Medicines and Healthcare Products Regulatory Agency (MHRA). The agency will be formed in April 2003 through a merger of the Medicines Control Agency and the Medical Devices Agency.

Professor Breckenridge is chairman of the Committee on Safety of Medicines, a post he will relinquish in April next year. He will be working between two and three days a week for the MHRA until then, concentrating on the appointment of its chief executive and its new board, which will include external members as non-executives.